Loading...
Chemical structure of NMDAR antagonist 1

GC34352

NMDAR antagonist 1

Also known as (1S)-7-bromo-N-[2-(4-hydroxyphenyl)ethyl]-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline-1-carboxamide

NMDAR antagonist 1 is a potent and orally bioavailable NR2B-selective NMDAR antagonist

ChemicalCAS2220162-06-9MW414.3FormulaC20H20BrN3O2
CAS number
2220162-06-9
Molecular weight
414.3
Formula
C20H20BrN3O2
Solubility
DMSO ： 5 mg/mL (12·07 mM);Water ： ＜ 0·1 mg/mL (insoluble)
InChIKey
NCHFPVRYYJGAJY-SFHVURJKSA-N
Catalogue number
GC34352
Brand
GLPBIO
Computed properties PubChem CID 145710206 · XLogP 2.7 · TPSA 64.9 Ų · H-bond donors 2
XLogP
2.7
TPSA
64.9 Ų
H-bond donors
2
H-bond acceptors
3
Rotatable bonds
4
Heavy atoms
26

SMILES C1CC2=NC3=C(CN2[C@@H]1C(=O)NCCC4=CC=C(C=C4)O)C=C(C=C3)Br

Computed descriptors from PubChem (CID 145710206), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.